Business
Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics
Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Daewoong Pharmaceutical Co., Ltd. Daewoong Pharmaceutical gains access to Salipro Biotech's expertise and Salipro® platform for stabilizing challenging membrane proteins (e.g., GPCRs, ion channels, transporters). The collaboration will target a specific membrane protein to aid Daewoong's development of novel small molecule drugs.
About this update from Daewoong Pharmaceutical Co., Ltd.
[{"type":"text","content":"- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug discovery programs for the generation of small molecule drugs.","length":253,"tagName":"p"},{"type":"text","content":"SEOUL, South Korea, June 11, 2025 /PRNewswire/ -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Daewoong Pharmaceutical Co., Ltd. Daewoong Pharmaceutical gains access to Salipro Biotech's expertise and Salipro® platform for stabilizing challenging membrane proteins (e.g., GPCRs, ion channels, transporters). The collaboration will target a specific membrane protein to aid Daewoong's development of novel small molecule drugs.","length":503,"tagName":"p"},{"type":"image","alt":"Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics","displaySize":"","headline":null,"caption":"Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":281,"url":"https://media.zenfs.com/en/prnewswire.com/d1ae04410637484128c7c1c0b7cd6c15"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RUygmyVBib78yyzw95sWwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ5NTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d1ae04410637484128c7c1c0b7cd6c15","width":400,"height":281}},"href":"https://mma.prnewswire.com/media/2708194/Photo__Salipro_Biotech__DAEWOONG_CI.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Under the terms of this agreement, the collaboration will enable Daewoong Pharma to leverage Salipro Biotech´s expertise and proprietary platform to advance their drug discovery efforts in the development of novel therapeutic small molecules against a challenging membrane protein drug target.","length":293,"tagName":"p"},{"type":"text","content":""We are excited to join forces with Daewoong Pharmaceutical and contribute with our proprietary Salipro® platform to accelerate the development of novel therapeutic drugs for Daewoong Pharmaceutical's pipeline", said Jens Frauenfeld, CEO of Salipro Biotech. "This partnership is particularly...